Nonsteroidal anti-androgen, originally a prostate cancer drug
mitochondrial pyruvate carrier (MPC) inhibitor by Pelage in early trials
Topical anti-androgen sold as a cosmetic lotion
a synthetic anti-androgen and weak progestogen that inhibits DHT binding to androgen receptor